Efficacy of psychosocial interventions for smoking cessation in patients with coronary heart disease: A systematic review and meta-analysis

Annals of Behavioral Medicine

Volumn 32, Issue 1, 2006, Pages 10-20

  Barth, Jürgen ^a   Critchley, Julia ^b   Bengel, Jürgen ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABSTINENCE; ADULT; BEHAVIOR THERAPY; CARDIAC PATIENT; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INTERVENTION STUDY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SELF HELP; SMOKING CESSATION; SOCIAL PSYCHOLOGY; SYSTEMATIC REVIEW;

CORONARY DISEASE; HUMANS; PSYCHOLOGY; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 33745948739     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15324796abm3201_2     Document Type: Review

References (84)

1. Keil U, Liese AD, Hense HW, et al.: Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. European Heart Journal. 1998, 19:1197-1207.
2. Willett WC, Green A, Stampfer MJ, et al.: Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. The New England Journal of Medicine. 1987, 317:1303-1309.
3. Tunstall-Pedoe H, Woodward M, Tavendale R, A'Brook R, McCluskey MK: Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: Cohort study. British Medical Journal. 1997, 315:722-729.
4. Aberg A, Bergstrand R, Johansson S, et al.: Cessation of smoking after myocardial infarction: Effects on mortality after 10 years. British Heart Journal. 1983, 49:416-422.
5. Critchley JA, Capewell S: Mortality risk reduction associated with coronary heart disease: A systematic review. Journal of the American Medical Association. 2003, 290:86-97.
6. Wilson K, Gibson N, Willan A, Cook D: Effect of smoking cessation on mortality after myocardial infarction. Archives of Internal Medicine. 2000, 160:939-944.
7. Barth J, Bengel J: Smoking cessation in patients with coronary heart disease: Risk reduction and an evaluation of the efficacy of interventions. In Jordan J, Bardé B, Zeiher A (eds), Evidence Based Psychocardiology. Washington, DC: American Psychological Association, 2006.
8. Silagy C, Stead L: Physician Advice for Smoking Cessation. Retrieved March 3, 2004 from the Cochrane Library.
9. Stead L, Lancaster T: Group Behaviour Therapy Programmes for Smoking Cessation. Retrieved March 3, 2004 from Cochrane Database of Systematic Reviews.
10. Lancaster T, Stead L: Individual Behavioural Counselling for Smoking Cessation. Retrieved March 3, 2004 from Cochrane Database of Systematic Reviews.
11. Stead L, Lancaster T, Perera R: Telephone Counselling for Smoking Cessation. Retrieved March 3, 2003 from Cochrane Database of Systematic Reviews.
12. Lancaster T, Stead L: Self-Help Interventions for Smoking Cessation. Retrieved March 3, 2004 from Cochrane Database of Systematic Reviews.
13. Rigotti NA, Munafo MR, Murphy MFG, Stead L: Interventions for smoking cessation in hospitalised patients. Retrieved March 3, 2004 from Cochrane Database of Systematic Reviews.
14. Rice VH, Stead L: Nursing Interventions for Smoking Cessation. Retrieved March 3, 2004 from the Cochrane Library.
15. van der Meer RM, Wagena EJ, Ostelo RWJG, Jacobs JE, von Schayck CP: Smoking Cessation for Chronic Obstructive Pulmonary Disease. Retrieved March 3, 2004 from the Cochrane Library.
16. Wiggers LCW, Smets EMA, DeHaes JCJM, Peters RJG, Legemate DA: Smoking cessation interventions in cardiovascular patients. European Journal of Endovascular Surgery. 2003, 26:467-475.
17. De Backer G, Ambrosioni E, Borch-Johnson K, et al.: European guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal. 2003, 24:1601-1610.
18. Ockene IS, Miller NH: Cigarette smoking, cardiovascular disease, and stroke: A statement for healthcare professionals from the American Heart Association. Circulation. 1997, 96:3243-3247.
19. American Heart Association: ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. Retrieved May 27, 2004 from http://www.americanheart.org/ downloadable/heart/1016214837537UANSTEMI2002Web.pdf
20. Davidson KW, Trudeau KJ, Ockene JK, Orleans CT, Kaplan RM: A primer on current evidence-based review systems and their implications for behavioral medicine. Annals of Behavioral Medicine. 2004, 28:226-238.
21. Bolman C, de Vries H, van Breukelen G: Evaluation of a nurse-managed minimal-contact smoking cessation intervention for cardiac inpatients. Health Education Research. 2002, 17:99-116.
22. Hedbäck B, Perk J: 5-year results of a comprehensive rehabilitation program after myocardial infarction. European Heart Journal. 1987, 8:234-242.
23. Jolly K, Bradley F, Sharp S, et al.: Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina. Final results of the Southampton heart integrated care project (SHIP). British Medical Journal. 1999, 318:706-711.
24. Barber K, Stommel M, Kroll J, Holmes-Rovner M: Cardiac rehabilitation for community-based patients with myocardial - infarction: Factors predicting discharge recommendation and participation. Journal of Clinical Epidemiology. 2001, 54:1025-1030.
25. de Valle MN, Norman P: Causal attributions, health locus of control beliefs and lifestyle changes among pre-operative coronary patients. Psychology and Health. 1992, 7:201-211.
26. Engblom E, Rönnemaa T, Hömölöinen H, et al.: Coronary heart disease risk factors before and after bypass surgery: Results of a controlled trial on multifactorial rehabilitation. European Heart Journal. 1992, 13:232-237.
27. Baughman KI, Hutter AMJ, DeSanctis RW, Kallman CH: Early discharge following acute myocardial infarction. Long-term follow-up of randomized patients. Archives of Internal Medicine. 1982, 142:875-878.
28. Fridlund B, Högstedt B, Lidell E, Larsson PA: Recovery after myocardial infarction: Effects of a caring rehabilitation program. Scandinavian Journal of Caring Sciences. 1991, 5:23-32.
29. Campbell NC, Thain J, Deans HG, et al.: Secondary prevention clinics for coronary heart disease: Randomised trial of effect on health. British Medical Journal. 1998, 316:1434-1437.
30. Schmitz JM, Spiga R, Rhoades HM, Fuentes F, Grabowski J: Smoking cessation in women with cardiac risk: A comparative study of two theoretically based therapies. Nicotine & Tobacco Research. 1999, 1:87-94.
31. Prochaska JO, DiClemente CC: The transtheoretical approach. In Norcross JC (ed), Handbook of Eclectic Psychotherapy. New York: Brunner/Mazel, 1986, 163-200.
32. Rollnick S, Butler CC, Stott N: Helping smokers make decisions: The enhancement of brief intervention for general medical practice. Patient Education and Counseling. 1997, 31:191-203.
33. Rosal MC, Ockene JK, Ma Y, et al.: Coronary Artery Smoking Intervention Study (CASIS): 5-year follow-up. Health Psychology. 1998, 17:476-478.
34. Rigotti NA, McKool KM, Shiffman S: Predictors of smoking cessation after coronary artery bypass graft surgery: Results of a randomized trial with 5-year follow-up. Annals of Internal Medicine. 1994, 120:287-293.
35. Hall SM, Delucchi KL, Velicer WF, et al.: Statistical analysis of randomized trials in tobacco treatment: Longitudinal designs with dichotomous outcome. Nicotine & Tobacco Research. 2001, 3:193-202.
36. Haskell WL, Alderman EL, Fair JM, et al.: Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation. 1994, 89:975-990.
37. Velicer WF, Prochaska JO: A comparison of four self-report smoking cessation outcome measures. Addictive Behaviors. 2004, 29:51-60.
38. Velicer WF, Prochaska JO, Rossi JS, Snow MG: Assessing outcome in smoking cessation studies. Psychological Bulletin. 1992, 111:23-41.
39. Cochrane Collaboration: Review Manager 4.2. Retrieved April 27, 2004 from http://www.cc-ims.net/RevMan
40. Higgins JPT, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. British Medical Journal. 2003, 327:557-560.
41. Deeks J, Group SMW: Statistical methods programmed in meta view. Retrieved April 27, 2004 from http://www.cochrane.org/docs/statisticalmethods. pdf
42. Allen JK: Coronary risk factor modification in woman after coronary artery bypass surgery. Nursing Research. 1996, 45:260-265.
43. Burt A, Thornley R, Illingworth D, et al.: Stopping smoking after myocardial infarction. Lancet. 1974, 1:304-306.
44. Carlsson R, Lindberg G, Westin L, Israelsson B: Influence of coronary nursing management follow up on lifestyle after acute myocardial infarction. Heart. 1997, 77:256-259.
45. Ockene JK, Kristeller J, Goldberg R, et al.: Smoking cessation and severity of disease: The coronary artery smoking intervention study. Health Psychology: 1992, 11:119-126.
46. DeBusk RF, Miller N, Superko HR, et al.: A case-management system for coronary risk factor modification after acute myocardial infarction. Annals of Internal Medicine. 1994, 120:721-729.
47. Dornelas EA, Sampson RA, Gray JF, Waters D, Thompson PD: A randomized controlled trial of smoking cessation counseling after myocardial infarction. Preventive Medicine. 2000, 30:261-268.
48. Feeney GFX, McPherson A, Connor JP, et al.: Randomized controlled trial of two cigarette quit programmes in coronary care patients after acute myocardial infarction. Internal Medicine Journal. 2001, 31:470-475.
49. Hajek P, Taylor TZ, Mills P: Brief intervention during hospital admission to help patients to give up smoking after myocardial infarction and bypass surgery: Randomised controlled trial. British Medical Journal. 2002, 324:1-5.
50. Heller RF, Knapp JC, Valenti LA, Dobson AJ: Secondary prevention after acute myocardial infarction. American Journal of Cardiology. 1993, 72:759-762.
51. Lisspers J, Sundin O, Hofman-Bang C, et al.: Behavioral effects of a comprehensive, multifactorial program for lifestyle change after percutaneous transluminal coronary angioplasty. A prospective, randomized, controlled study. Journal of Psychosomatic Research. 1999, 46:143-154.
52. Mitsibounas DN, Tsouna-Hadjis ED, Sideris DA, Rotas AR: Effects of group psychosocial intervention on coronary risk factors. Psychotherapy and Psychosomatics. 1992, 58:97-102.
53. Ortigosa Moreno A, Ochoa Gomez FJ, Ramalle Gomara E, et al.: Eficacia de una intervencion para dejar de fumar en pacientes con infarto de miocardio [Efficacy of a smoking cessation intervention for patients with myocardial infarction]. Medicina Clinica (Barc). 2000, 114:209-210.
54. Quist-Paulsen P, Gallefoss F: Randomised controlled trial of smoking cessation intervention after admission for coronary heart disease. British Medical Journal. 2003, 327:1254-1257.
55. Reid R, Pipe A, Higginson L, et al.: Stepped care approach to smoking cessation in patients hospitalized for coronary artery disease. Journal of Cardiopulmonary Rehabilitation. 2003, 23:176-182.
56. Sivarajan ES, Newton KM, Almes MJ, et al.: Limited effects of outpatient teaching and counseling after myocardial infarction: a controlled study. Heart and Lung. 1983, 12:65-73.
57. Taylor CB, Houston-Miller N, Killen JD, DeBusk RF: Smoking cessation after acute myocardial infarction: effects of a nurse-managed intervention. Annals of Internal Medicine. 1990, 113:118-123.
58. van Elderen T, Maes S, Seegers G: Effects of a post-hospitalization group health education programme for patients with coronary heart disease. Psychology and Health. 1994, 9:317-330.
59. van Elderen T, Maes S, van den Broek Y: Effects of a health education programme with telephone follow-up during cardiac rehabilitation. British Journal of Clinical Psychology. 1994, 33:367-378.
60. Schulz KF, Grimes DA: Generation of allocation sequences in randomised trials: Chance, not choice. Lancet. 2002, 359:515-519.
61. Schulz KF, Grimes DA: Allocation concealment in randomised trials: Defending against deciphering. Lancet. 2002, 359:614-618.
62. Jüni P, Altman G, Egger M: Assessing the quality of controlled clinical trials. British Medical Journal. 2001, 323:42-46.
63. Woodward M, Tunstall-Pedoe H: Biochemical evidence of persistent heavy smoking after a coronary diagnosis despite self-reported reduction: analysis from the Scottish Heart Health Study. European Heart Journal. 1992, 13:160-165.
64. Patrick DL, Cheadle A, Thompson DC, et al.: The validity of self-reported smoking: A review and meta-analysis. American Journal of Public Health. 1994, 84:1086-1093.
65. Begg C, Cho M, Eastwood S, et al.: Improving the quality of reporting of randomized controlled trials: The CONSORT statement. Journal of the American Medical Association. 1996, 276:637-639.
66. Silagy C, Lancaster T, Stead L, Mant D, Fowler G: Nicotine replacement therapy for smoking cessation. Retrieved February 6, 2005, from Cochrane Library.
67. Fiore MC, Smith SS, Jorenby DE, Baker TB: The effectiveness of the nicotine patch for smoking cessation: A meta-analysis. Journal of the American Medical Association. 1994, 271:1940-1947.
68. Fredrickson PA, Hurt RDL, Wingender L, et al.: High dose transdermal nicotine therapy for heavy smokers: Safety, tolerability and measurement of nicotine and cotinine levels. Psychopharmacology. 1995, 122:215-222.
69. Ottervanger JP, Festen JM, de Vries AG, Stricker BH: Acute myocardial infarction while using the nicotine patch. Chest. 1995, 107:1765-1766.
70. Keeley EC, Pirwitz MJ, Landau C, et al.: Intranasal nicotine spray does not augment the adverse effects of cigarette smoking on myocardial oxygen demand or coronary arterial dimensions. The American Journal of Medicine. 1996, 101:357-363.
71. Tzivoni D, Keren A, Meyler S, et al.: Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking. Cardiovascular Drugs and Therapy. 1998, 12:239-244.
72. Tanus-Santos JE, Toledo JCY, Cittadino M, et al.: Cardiovascular effects of transdermal nicotine in mildly hypertensive smokers. American Journal of Hypertension. 2001, 14:610-614.
73. Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease: Nicotine replacement therapy for patients with coronary artery disease. Archives of Internal Medicine. 1994, 154:989-995.
74. Joseph AM, Norman SM, Ferry LH, et al.: The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. The New England Journal of Medicine. 1996, 335:1792-1798.
75. Joseph AM, Fu SS: Safety issues in pharmacotherapy for smoking in patients with cardiovascular disease. Progress in Cardiovascular Diseases. 2003, 45:429-441.
76. Benowitz NL, Gourlay SG: Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. Journal of American College of Cardiology. 1997, 29:1422-1431.
77. Spinler SA, Hilleman DE, Cheng JWM, et al.: New recommendations from the 1999- American College of Cardiology/American Heart Association acute myocardial infarction guidelines. The Annals of Pharmacotherapy. 2001, 35:589-617.
78. McRobbie H, Hajek P: Nicotine replacement therapy in patients with cardiovascular disease: Guidelines for health professionals. Addiction. 2001, 96:1547-1551.
79. Wulsin LR, Bonita S: Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosomatic Medicine. 2003, 65:201-210.
80. Barth J, Schumacher M, Herrmann-Lingen C: Depression as a risk factor for mortality in patients with coronary heart disease: A meta-analysis. Psychosomatic Medicine. 2004, 66:802-813.
81. Hughes J, Stead L, Lancaster T: Antidepressants for smoking cessation. Retrieved February 22, 2005 from the Cochrane Library.
82. Tonstad S, Farsang C, Klaene G, et al.: Bupropion SR for smoking cessation in smokers with cardiovascular disease: A multicenter randomised study. European Heart Journal. 2003, 24:946-955.
83. Riemsma RP, Pattenden J, Bridle C, Sowden A, Mather L: Systematic review of the effectiveness of stage based interventions to promote smoking cessation. British Medical Journal. 2003, 326:1175-1182.
84. vanSluis EMF, vanPoppel MNM, vanMechelen W: Stage-based lifestyle interventions in primary care. Are they effective? American Journal of Preventive Medicine. 2004, 26:330-343.